drug_testing_2019

Chinese company starts mass producing Gilead coronavirus drug

February 12, 2020
Research and Development Ebola, Wuhan, Wuhan Coronavirus, china coronavirus

A drugmaker in China said it has started mass producing Gilead Sciences Ebola drug that has the potential to fight …

lilly_building_with_american_flag_web

Eli Lilly’s solanezumab fails at Phase 2/3 in early-onset Alzheimer’s disease

February 11, 2020
Manufacturing and Production Alzheimer's Eli Lilly, pharma, trial failure

In another blow to Alzheimer’s research, it has emerged that a study investigating Eli Lilly’s solanezumab in the treatment of …

five-clear-glass-vial-bottles

Scotland approves targetted combination therapy for advanced melanoma

February 11, 2020
Manufacturing and Production NHS, SMC, Scotland, UK, advanced melanoma, melanoma

The Scottish Medicines Consortium (SMC) has approved targeted combination therapy for the treatment of adult patient with unresectable or metastatic …

type_2_diabetes_28081593711

Type 2 diabetes cases up 40% in Scotland

February 11, 2020
Manufacturing and Production Type 1 diabetes, diabetes, diabetes obesity, obesity, type 2 diabetes

According to a new study, Scotland’s cases of type 2 diabetes has increased by 40% over the last 10 years. …

libtayo

Sanofi and Regeneron’s Libtayo approved on NHS Scotland for cutaneous squamous cell carcinoma

February 11, 2020
Manufacturing and Production, Sales and Marketing Libtayo, NHS, Regeneron, Sanofi, Scotland, nhs scotland, pharma

Scottish patients will now be able to access Sanofi and Regeneron’s Libtayo (cemiplimab) via the NHS after it became known …

flu_shot_2019

Patient successfully treated for coronavirus in the US

February 11, 2020
Manufacturing and Production Chinese Coronavirus, Coronavirus Wuhan, Ebola, Wuhan Coronavirus, coronavirus

Health officials in the US say they have successfully treated a man for coronavirus with an experimental drug. The Ebola …

alzheimers

Roche’s experimental Alzheimer’s drug does not meet primary endpoint in clinical trials

February 10, 2020
Sales and Marketing Alzheimer's, Roche, roche Alzheimer

Roche has said its experimental drug, gantenerumab, did not meet its primary endpoint in people who have an inherited form …

screenshot-2019-06-27-at-13

Nanoform establishes US subsidiary

February 10, 2020
Sales and Marketing nano, nano science, nanotech

Nanoform has set up an American subsidiary, ‘Nanoform USA’, due to increasing demand for the companies CESS technology.Its patented CESS …

absent_nasal_bone

FDA approves Caption Health’s AI-guided imaging system

February 10, 2020
Sales and Marketing AI, Caption Health, FDA, ultrasound, ultrasound imaging

The FDA have given marketing approval for Caption Health’s Caption Guidance and its use in cardiac ultrasound images.The technology allows …

6507102201_ab7cda0ed0_b

Several European cases of coronavirus traced to ski resort in the Alps

February 10, 2020
Sales and Marketing china coronavirus, coronavirus, vietnam coronavrisu, wuhan cornavirus

Multiple European cases of coronavirus have been traced to a ski resort in the Alps, with a British man spread …

Vietnam develops quick coronavirus test kit

February 10, 2020
Sales and Marketing Wuhan Coronavirus, china coronavirus, coronavirus, vietnam, vietnam coronavirus

Researchers in Vietnam have developed a coronavirus test kit which provides results in 70 minutes instead of four hours like …

1740294_bertil-lindmark-webbnyhet

Galecto hires new Chief Medical Officer

February 7, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Galecto

Galecto has announced Bertil Lindmark as their new Chief Medical Officer. He began his posting on 1 February 2020.Lindmark joins …

rob_van_maanen

New Chief Medical Officer joins Khondrion

February 7, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Khondrion has revealed that Dr Rob van Maanen has joined the company as its new Chief Medical Officer (CMO). Dr …

top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

February 7, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MERS, Sars, china coronavirus, coronavirus, coronavirus China, wuhan coronaviurs

The Wuhan coronavirus continues to dominate the news, with China admitting its handling of the crisis had shortcomings while Gilead …

shutterstock_349943306

85% of patients see benefit in clinical trials, but 43% were never given the option to participate, report finds

February 7, 2020
Medical Communications, Research and Development clinical trials, pharma

Patients regularly find value in participating in clinical trials, but many are not given the option by medical professionals and …

army_trainers_teach_nhs_medics_how_to_put_on_ebola_safety_suits_15650293350

Third person in the UK diagnosed with coronavirus

February 7, 2020
Medical Communications China, Coronavirus Wuhan, MERS, Sars, coronavirus, coronavirus China

A third British person has been diagnosed with the coronavirus, which he allegedly  caught in Singapore.He was tested in Brighton …

gsk_boronia_australia

GSK to axe 720 positions at Belgian vaccine facility

February 7, 2020
Manufacturing and Production, Medical Communications GSK, job cuts, pharma

GlaxoSmithKline has announced a cull of staff at its vaccine production site in Belgium, with 720 employees facing the axe. …

26795063175_fe37f336f7_b

Jury orders Johnson & Johnson to pay $750 million in latest baby powder case

February 7, 2020
Medical Communications J&J, JJ, Johnson & Johnson, ovarian cancer, talc, talc powder

Johnson & Johnson have been ordered to pay by a jury $750 million to four plaintiffs over the company’s baby …

abbvie_0

AbbVie’s Rinvoq hits target in psoriatic arthritis sub-population at Phase 3

February 6, 2020
Research and Development AbbVie, Rinvoq, pharma, psoriatic arthritis

AbbVie has unveiled new Phase 3 data on its selective and reversible JAK inhibitor Rinvoq (upadacitinib) in the treatment of …

The Gateway to Local Adoption Series

Latest content